Scarica l'app Stockscreener
4.03
6.33%
0.24
Dopo l'orario di chiusura:
3.95
-0.08
-1.99%
Precedente Chiudi:
$3.79
Aprire:
$3.85
Volume 24 ore:
1.31M
Relative Volume:
1.02
Capitalizzazione di mercato:
$512.71M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-44.78
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
+3.87%
1M Prestazione:
+16.81%
6M Prestazione:
-22.50%
1 anno Prestazione:
-22.94%
Intervallo 1D:
$3.83
$4.09
Intervallo di 1 settimana:
$3.68
$4.19
Portata 52W:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.03 | 482.18M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
131.02 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.64 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.61 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.08 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.93 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Biosciences Showcases Cell Analysis Innovation at UBS, Wells Fargo, Morgan Stanley Events - Stock Titan
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cytek Biosciences (CTKB), Natera (NTRA) and Warby Parker (WRBY) - The Globe and Mail
Mixed Analyst Opinions on Healthcare Stocks Cytek Biosciences, Natera, and Warby Parker - AInvest
Cytek Biosciences Earnings Call Reveals Mixed Outlook - TipRanks
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q2 2025 Earnings Call Transcript - Insider Monkey
Cytek Biosciences Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cytek Biosciences Narrows FY25 Revenue Guidance to $196M-$200M - AInvest
Cytek narrows 2025 revenue outlook to $196M-$205M amid recurring revenue growth and new product launches - MSN
Cytek Biosciences 2025 Q2 Earnings Loss Narrows 50% as Revenue Slides 2.2% - AInvest
Cytek Biosciences Narrows 2025 Revenue Outlook to $196M-$205M Amid Recurring Revenue Growth and New Product Launches - AInvest
Cytek's 2025 Q2 Earnings: Navigating Contradictions in Sales, Margins, and Market Growth - AInvest
Earnings call transcript: Cytek Biosciences Q2 2025 misses revenue forecast - Investing.com
Cytek Biosciences: Q2 2025 Financial Performance Overview - TipRanks
Cytek Biosciences, Inc. (CTKB) Beats Q2 Earnings Estimates - sharewise.com
Transcript : Cytek Biosciences, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Cytek Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Cytek Biosciences, Inc. SEC 10-Q Report - TradingView
Cytek Biosciences earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Cytek Biosciences Reports Second Quarter 2025 Financial Results - GlobeNewswire
Cytek Reports Mixed Q2 Results: Recurring Revenue Jumps 16% While Total Revenue Dips 2% - Stock Titan
Cytek Biosciences Inc. Stock Analysis and ForecastTremendous gains - Jammu Links News
What makes Cytek Biosciences Inc. stock price move sharplyUnlock exclusive stock analysis for investors - Jammu Links News
How does Cytek Biosciences Inc. compare to its industry peersMaximize your returns with smart trade entries - Jammu Links News
Is Cytek Biosciences Inc. a growth stock or a value stockBuild a winning portfolio with smart picks - Jammu Links News
What are the technical indicators suggesting about Cytek Biosciences Inc.Breakthrough capital growth - Jammu Links News
Does Cytek Biosciences Inc. stock perform well during market downturnsHigh-profit stock alerts - Jammu Links News
Should I hold or sell Cytek Biosciences Inc. stock in 2025Invest confidently with professional market insights - Jammu Links News
Is it the right time to buy Cytek Biosciences Inc. stockBuild your wealth with consistent stock growth - Jammu Links News
What catalysts could drive Cytek Biosciences Inc. stock higher in 2025Discover stock picks with superior returns - Jammu Links News
How strong is Cytek Biosciences Inc. company’s balance sheetFree Expert Stock Watchlist - Jammu Links News
What are the latest earnings results for Cytek Biosciences Inc.Capitalize on fast-moving trading opportunities - Jammu Links News
Can machine learning forecast Cytek Biosciences Inc. recoverySafe Momentum Strategy With Trend Analysis - Newser
Multi asset correlation models including Cytek Biosciences Inc.Institutional Holding Behavior Pattern Analysis - Newser
Using Bollinger Bands to evaluate Cytek Biosciences Inc.Real-Time AI Sentiment and Price Forecast - Newser
Real time social sentiment graph for Cytek Biosciences Inc.Free Weekly Hot Picks With Buy Confidence - Newser
Cytek Biosciences Inc.’s volatility index tracking explainedTrade Setups With AI Powered Filters Published - metal.it
Can Cytek Biosciences Inc. hit a new high this monthShort Term Opportunity Finder with Tools - Newser
Is Cytek Biosciences Inc. Stock Overbought or Oversold RSI Indicator AnalysisTrade Safety Matrix for Conservative Traders - Newser
Cytek Biosciences And 2 Other Penny Stocks Worth Watching - simplywall.st
How Interest Rate Changes Impact Cytek Biosciences Inc. Stock PerformanceEntry and Exit Strategy Optimizer Tool Tested - metal.it
What machine learning models say about Cytek Biosciences Inc.Risk Managed Intraday Trade Alerts Increase in Volume - metal.it
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.57%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):